Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India · Delayed Price · Currency is INR 1,788.00
+107.80 (6.42%)
Jul 31, 2026, 3:29 PM IST
Tatva Chintan Pharma Chem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 87.91 | 113.74 | 353.04 | 273.65 | 630.17 |
Short-Term Investments | - | - | 3.27 | 3.13 | 138.5 | 8.02 |
Trading Asset Securities | - | - | - | 100.51 | - | - |
Cash & Short-Term Investments | 87.91 | 87.91 | 117.01 | 456.68 | 412.15 | 638.19 |
Cash Growth | -37.64% | -24.87% | -74.38% | 10.80% | -35.42% | 1098.70% |
Accounts Receivable | - | 1,190 | 895.49 | 720.24 | 875.03 | 584.27 |
Other Receivables | - | - | 11.9 | 5.18 | 3.21 | 27.21 |
Receivables | - | 1,193 | 909.76 | 727.83 | 879.96 | 613.09 |
Inventory | - | 1,961 | 1,340 | 1,528 | 1,625 | 1,700 |
Prepaid Expenses | - | - | 49.29 | 55.84 | 37.1 | 21.22 |
Other Current Assets | - | 253.51 | 236.85 | 211.05 | 168.31 | 1,384 |
Total Current Assets | - | 3,495 | 2,652 | 2,979 | 3,123 | 4,356 |
Property, Plant & Equipment | - | 6,275 | 5,471 | 4,995 | 4,265 | 2,108 |
Long-Term Investments | - | 40 | - | - | - | - |
Other Intangible Assets | - | 68.26 | 58.99 | 39.61 | 4.76 | 3.17 |
Long-Term Deferred Tax Assets | - | 95.67 | 126.24 | 122.97 | 164.03 | 87.1 |
Other Long-Term Assets | - | 62.94 | 53.94 | 50.92 | 32.13 | 26.02 |
Total Assets | - | 10,037 | 8,362 | 8,187 | 7,589 | 6,581 |
Accounts Payable | - | 582.46 | 326.89 | 450.31 | 321.88 | 445.13 |
Accrued Expenses | - | 5.55 | 123.39 | 87.97 | 67.46 | 75.75 |
Short-Term Debt | - | - | 357.49 | 100 | 1,562 | 924.69 |
Current Portion of Long-Term Debt | - | 1,154 | 6.39 | 36.32 | 98.18 | 143.58 |
Current Income Taxes Payable | - | 3.17 | 20.16 | 0.76 | 2.13 | 10.23 |
Current Unearned Revenue | - | - | 70.22 | 21.72 | 33.12 | 18.38 |
Other Current Liabilities | - | 386.54 | 55.73 | 99.55 | 302.05 | 94.2 |
Total Current Liabilities | - | 2,131 | 960.27 | 796.63 | 2,387 | 1,712 |
Long-Term Debt | - | 50.1 | - | 6.39 | 42.3 | 131.11 |
Long-Term Unearned Revenue | - | - | - | - | - | 0.08 |
Pension & Post-Retirement Benefits | - | 25.89 | - | - | - | - |
Other Long-Term Liabilities | - | 12.01 | 13.98 | 13.34 | 11.45 | 6.51 |
Total Liabilities | - | 2,219 | 974.25 | 816.36 | 2,441 | 1,850 |
Common Stock | - | 233.92 | 233.92 | 233.92 | 221.65 | 221.65 |
Additional Paid-In Capital | - | - | 4,044 | 4,044 | 2,090 | 2,090 |
Retained Earnings | - | - | 3,085 | 3,077 | 2,825 | 2,415 |
Comprehensive Income & Other | - | 7,584 | 25.08 | 15.84 | 10.75 | 4.27 |
Shareholders' Equity | 7,818 | 7,818 | 7,388 | 7,371 | 5,148 | 4,731 |
Total Liabilities & Equity | - | 10,037 | 8,362 | 8,187 | 7,589 | 6,581 |
Total Debt | 1,204 | 1,204 | 363.88 | 142.71 | 1,703 | 1,199 |
Net Cash (Debt) | -1,116 | -1,116 | -246.87 | 313.97 | -1,290 | -561.19 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -47.72 | -47.71 | -10.55 | 13.72 | -58.22 | -26.10 |
Filing Date Shares Outstanding | 23.4 | 23.4 | 23.39 | 23.39 | 22.17 | 22.17 |
Total Common Shares Outstanding | 23.4 | 23.4 | 23.39 | 23.39 | 22.17 | 22.17 |
Working Capital | - | 1,364 | 1,692 | 2,182 | 735.59 | 2,644 |
Book Value Per Share | 334.03 | 334.03 | 315.84 | 315.10 | 232.25 | 213.44 |
Tangible Book Value | 7,749 | 7,749 | 7,329 | 7,331 | 5,143 | 4,728 |
Tangible Book Value Per Share | 331.12 | 331.12 | 313.32 | 313.41 | 232.04 | 213.30 |
Buildings | - | - | 1,698 | 1,544 | 504.8 | 376.53 |
Machinery | - | - | 4,107 | 3,005 | 1,478 | 1,153 |
Construction In Progress | - | - | 215.35 | 729.27 | 2,307 | 514.91 |